Literature DB >> 22707605

Valganciclovir treatment of primary cytomegalovirus pneumonitis in an immunocompetent adult.

Susan E Snape1, Pradhib Venkatesan.   

Abstract

Interstitial pneumonitis is a rare complication of cytomegalovirus (CMV) infection in the immunocompetent. There is a paucity of literature regarding treatment in these patients. A previously healthy, immunocompetent female patient presented with fever, shortness of breath, a dry non-productive cough and myalgia and was subsequently diagnosed with CMV interstitial pneumonitis. She was treated with valganciclovir and swiftly improved but experienced neutropenia, which resolved on treatment cessation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22707605      PMCID: PMC3063292          DOI: 10.1136/bcr.11.2010.3489

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.

Authors:  A Asberg; A Humar; H Rollag; A G Jardine; H Mouas; M D Pescovitz; D Sgarabotto; M Tuncer; I L Noronha; A Hartmann
Journal:  Am J Transplant       Date:  2007-07-19       Impact factor: 8.086

2.  Successful treatment of severe cytomegalovirus infection with ganciclovir in an immunocompetent host.

Authors:  J G McCormack; S D Bowler; J E Donnelly; C Steadman
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

Review 3.  Severe cytomegalovirus infection in immunocompetent patients.

Authors:  M Eddleston; S Peacock; M Juniper; D A Warrell
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 4.  [Interstitial pulmonitis due to the cytomegalovirus in an immunocompetent adolescent: treatment with ganciclovir].

Authors:  G Pellegrini; G Collo; M Barbi; A Binda; M Masarone
Journal:  Pediatr Med Chir       Date:  1996 May-Jun

5.  Ganciclovir for the treatment of cytomegalovirus pneumonia in an immunocompetent host.

Authors:  F A Manian; T Smith
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

6.  Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection.

Authors:  P S Buonuomo; P Maurizi; P Valentini; S Mastrangelo; I Lazzareschi; V Ridola; R Riccardi
Journal:  J Perinatol       Date:  2006-10       Impact factor: 2.521

7.  A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

Authors:  Daniel F Martin; Juan Sierra-Madero; Sharon Walmsley; Richard A Wolitz; Katherine Macey; Panos Georgiou; Charles A Robinson; Mary Jean Stempien
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

8.  Cytomegalovirus colitis mimicking ischemic colitis in an immunocompetent host.

Authors:  Daniel S Siegal; Naveed Hamid; Burke A Cunha
Journal:  Heart Lung       Date:  2005 Jul-Aug       Impact factor: 2.210

9.  A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.

Authors:  I D Pavlopoulou; V Ph Syriopoulou; H Chelioti; G L Daikos; D Stamatiades; A Kostakis; J N Boletis
Journal:  Clin Microbiol Infect       Date:  2005-09       Impact factor: 8.067

10.  Parenteral ganciclovir treatment of acute CMV infection in the immunocompetent host.

Authors:  R B Laing; R S Dykhuizen; C C Smith; P J Molyneaux
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 7.455

View more
  3 in total

1.  Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir.

Authors:  Niklas F Müller; Matthias Schampera; Gerhard Jahn; Nisar P Malek; Christoph P Berg; Klaus Hamprecht
Journal:  BMC Infect Dis       Date:  2016-01-19       Impact factor: 3.090

2.  Cytomegalovirus and Herpes Simplex Virus Co-Infection in an HIV-Negative Patient: A Case Report.

Authors:  Angelica C Gangemi; Sung H Choi; Zhiwei Yin; Mirela Feurdean
Journal:  Cureus       Date:  2021-02-08

3.  Cytomegalovirus infection in immunocompetent adults: Is observation still the best strategy?

Authors:  Sarah Nangle; Subhashis Mitra; Steven Roskos; Daniel Havlichek
Journal:  IDCases       Date:  2018-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.